| US 7,498,350 B2 | ||
| Oxazolidinones as antibacterial agents | ||
| Michael Barry Gravestock, Waltham, Mass. (US); Neil James Hales, Macclesfield (United Kingdom); Folkert Reck, Waltham, Mass. (US); and Fei Zhou, Waltham, Mass. (US) | ||
| Assigned to AstraZeneca AB, Sodertalje (Sweden) | ||
| Appl. No. 10/536,687 PCT Filed Nov. 24, 2003, PCT No. PCT/GB03/05091 § 371(c)(1), (2), (4) Date May 27, 2005, PCT Pub. No. WO2004/048350, PCT Pub. Date Jun. 10, 2004. |
||
| Claims priority of application No. 0227704.4 (GB), filed on Nov. 28, 2002; and application No. 0310828.9 (GB), filed on May 10, 2003. | ||
| Prior Publication US 2006/0116386 A1, Jun. 01, 2006 | ||
| Int. Cl. A61K 31/44 (2006.01); C07D 413/00 (2006.01) | ||
| U.S. Cl. 514—340 [546/271.4] | 15 Claims |
1. A compound of the formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof,
![]() ![]() R1b is HET1 or HET2, wherein
i) HET1 is an N-linked 5-membered, fully or partially unsaturated heterocyclic ring, containing either (i) 1 to 3 further
nitrogen heteroatoms or (ii) a further heteroatom selected from O and S together with an optional further nitrogen heteroatom;
which ring is optionally substituted on a C atom, other than a C atom adjacent to the linking N atom, by an oxo or thioxo
group; and/or which ring is optionally substituted on any available C atom, other than a C atom adjacent to the linking N
atom, by a substituent selected from RT as hereinafter defined and/or on an available nitrogen atom, other than a N atom adjacent
to the linking N atom, (provided that the ring is not thereby quaternised) by (1-4C)alkyl;
ii) HET2 is an N-linked 6-membered di-hydro-heteroaryl ring containing up to three nitrogen heteroatoms in total (including
the linking heteroatom), which ring is substituted on a suitable C atom, other than a C atom adjacent to the linking N atom,
by oxo or thioxo and/or which ring is optionally substituted on any available C atom, other than a C atom adjacent to the
linking N atom, by one or two substituents independently selected from RT as hereinafter defined and/or on an available nitrogen
atom, other than a N atom adjacent to the linking N atom, (provided that the ring is not thereby quaternised) by (1-4C)alkyl;
RT is selected from a substituent from the group:
(RTa1) hydrogen, halogen, (1-4C)alkoxy, (2-4C)alkenyloxy, (2-4C)alkenyl, (2-4C)alkynyl, (3-6C)cycloalkyl, (3-6C)cycloalkenyl,
(1-4C)alkylthio, amino, azido, cyano and nitro; or
(RTa2) (1-4C)alkylamino, di-(1-4C)alkylamino, and (2-4C)alkenylamino;
or RT is selected from the group
(RTb1) (1-4C)alkyl group which is optionally substituted by one substituent selected from hydroxy, (1-4C)alkoxy, (1-4C)alkylthio,
cyano and azido; or
(RTb2) (1-4C)alkyl group which is optionally substituted by one substituent selected from (2-4C)alkenyloxy, (3-6C)cycloalkyl,
and (3-6C)cycloalkenyl;
or RT is selected from the group
(RTc) a fully saturated 4-membered monocyclic ring containing 1 or 2 heteroatoms independently selected from O, N and S (optionally
oxidised), and linked via a ring nitrogen or carbon atom;
and wherein at each occurrence of an RT substituent containing an alkyl, alkenyl, alkynyl, cycloalkyl or cycloalkenyl moiety
in (RTa1) or (RTa2), (RTb1) or (RTb2), or (RTc) each such moiety is optionally substituted on an available carbon atom with
one, two, three or more substituents independently selected from F, Cl, Br, OH and CN;
R2a and R6a are independently selected from H, CF3, OMe, SMe, Me and Et;
R2b and R6b are independently selected from H, F, Cl, CF3, OMe, SMe, Me and Et;
R3a is selected from H, (1-4C)alkyl, cyano, Br, F, Cl, OH, (1-4C)alkoxy, —S(O)n(1-4C)alkyl (wherein n=0, 1, or 2), amino, (1-4C)alkylcarbonylamino, nitro, —CHO, —CO(1-4C)alkyl, —CONH2 and —CONH(1-4C)alkyl;
R4 is selected from R4a and R4b, wherein
R4a is selected from azido, —NR7R8, OR10, (1-4C)alkyl, (1-4C)alkoxy, (3-6C)cycloalkyl, —(CH2)k—R9, AR1, AR2, (1-4C)alkanoyl, —CS(1-4C)alkyl, —C(═W)NRvRw [wherein W is O or S, Rv and Rw are independently H, or (1-4C)alkyl],
—(C═O)1—R6, —COO(1-4C)alkyl, —C═OAR1, —C═OAR2, —COOAR1, S(O)n(1-4C)alkyl (wherein n=1 or 2), —S(O)pAR1, —S(O)pAR2 and —C(═S)O(1-4C)alkyl;
wherein any (1-4C)alkyl chain may be optionally substituted by (1-4C)alkyl, cyano, hydroxy or halo; p=0, 1 or 2;
R4b is selected from HET-3;
R6 is selected from hydrogen, (1-4C)alkoxy, amino, (1-4C)alkylamino and hydroxy(1-4C)alkylamino;
k is 1 or 2;
1 is 1 or 2;
R7 and R8 are independently selected from H and (1-4C)alkyl, or wherein R7 and R8 taken together with the nitrogen to which they are attached can form a 5-7 membered ring optionally with an additional heteroatom
selected from N, O, S(O)n (wherein n=1 or 2) in place of 1 carbon atom of the so formed ring; wherein the ring may be optionally
substituted by one or two groups independently selected from (1-4C)alkyl, (3-6C)cycloalkyl, (1-4C)alkanoyl, —COO(1-4C)alkyl,
—S(O)n(1-4C)alkyl (wherein n=1 or 2), AR1, AR2, —C═OAR1, —C═OAR2, —COOAR1, —CS(1-4C)alkyl, —C(═S)O(1-4C)alkyl, —C(═W)NRvRw
[wherein W is O or S, Rv and Rw are independently H, or (1-4C)alkyl], —S(O)pAR1 and —S(O)pAR2; wherein any (1-4C)alkyl, (3-6C)cycloalkyl
or (1-4C)alkanoyl group may be optionally substituted (except on a carbon atom adjacent to a heteroatom) by one or two substituents
selected from (1-4C)alkyl, cyano, hydroxy, halo, amino, (1-4C)alkylamino and di(1-4C)alkylamino; p=0, 1 or 2;
R9 is independently selected from R9a to R9d below:
R9a: AR1, AR2, AR2a, AR2b, AR3, AR3a, AR3b, AR4, AR4a, CY1, CY2;
R9b: cyano, carboxy, (1-4C)alkoxycarbonyl, —C(=W)NRvRw [wherein W is O or S, Rv and Rw are independently H, or (1-4C)alkyl and
wherein Rv and Rw taken together with the amide or thioamide nitrogen to which they are attached can form a 5-7 membered ring
optionally with an additional heteroatom selected from N, O, S(O)n in place of 1 carbon atom of the so formed ring; wherein
when said ring is a piperazine ring, the ring may be optionally substituted on the additional nitrogen by a group selected
from (1-4C)alkyl, (3-6C)cycloalkyl, (1-4C)alkanoyl, —COO(1-4C)alkyl, —S(O)n (1-4C)alkyl (wherein n=1 or 2), —COOAR1, —CS(1-4C)alkyl
and —C(═S)O(1-4C)alkyl; wherein any (1-4)alkyl, (3-6C)cycloalkyl or (1-4C)alkanoyl group may itself optionally be substituted
by cyano, hydroxy or halo)], ethenyl, 2-(1-4C)alkylethenyl, 2-cyanoethenyl, 2-cyano-2-((1-4C)alkyl)ethenyl, 2-nitroethenyl,
2-nitro-2-((1-4C)alkyl)ethenyl, 2-((1-4C)alkylaminocarbonyl)ethenyl, 2-((1-4C)alkoxycarbonyl)ethenyl, 2-(1-4C)alkoxycarbonyl)ethenyl,
2-(AR1)ethenyl, 2-(AR2)ethenyl, 2-(AR2a)ethenyl;
R9c: (1-6C)alkyl
{optionally substituted by one or more groups (including geminal disubstitution) each independently selected from hydroxy,
(1-10C)alkoxy, (1-4C)alkoxy-(1-4C)alkoxy, (1-4C)alkoxy-(1-4C)alkoxy-(1-4C)alkoxy, (1-4C)alkylcarbonyl, phosphoryl [—O—P(O)(OH)2, and mono- and di-(1-4C)alkoxy derivatives thereof], phosphiryl [—O—P(OH)2 and mono- and di-(1-4C)alkoxy derivatives thereof], and amino; and/or optionally substituted by one group selected from carboxy,
phosphonate [phosphono, —P(O)(OH)2, and mono- and di-(1-4C)alkoxy derivatives thereof], phosphinate [—P(OH)2 and mono- and di-(1-4C)alkoxy derivatives thereof], cyano, halo, trifluoromethyl, (1-4C)alkoxycarbonyl, (1-4C)alkoxy-(1-4C)alkoxycarbonyl,
(1-4C)alkoxy-(1-4C)alkoxy-(1-4C)alkoxycarbonyl, (1-4C)alkylamino, di((1-4C)alkyl)amino, (1-6C)alkanoylamino-, (1-4C)alkoxycarbonylamino-,
N-(1-4C)alkyl-N-(1-6C)alkanoylamino-, —C(═W)NRvRw [wherein W is O or S, Rv and Rw are as hereinbefore defined], (═NORv) wherein
Rv is as hereinbefore defined, (1-4C)alkylS(O)pNH, (1-4C)alkylS(O)p-((1-4C)alkyl)N—, fluoro(1-4C)alkylS(O)pNH—, fluoro(1-4C)alkylS(O)p((1-4C)alkyl)N—, (1-4C)alkylS(O)q—, CY1, CY2, AR1, AR2, AR3, AR1-O—, AR2-O—, AR3-O—, AR1-S(O)q—, AR2-S(O)q—, AR3-S(O)q—, AR1-NH—, AR2-NH—, AR3-NH— (p is 1 or 2 and q is 0, 1 or 2), and also AR2a, AR2b, AR3a and AR3b versions of AR2 and AR3
containing groups}; wherein any (1-4C)alkyl present in any substituent on R9c may itself be substituted by one or two groups
independently selected from cyano, hydroxy, halo, amino, (1-4C)alkylamino and di(1-4C)alkylamino, provided that such a substituent
is not on a carbon adjacent to a heteroatom atom if present;
R9d: R14C(O)O(1-6C)alkyl- wherein R14 is AR1, AR2, (1-4C)alkylamino, benzyloxy-(1-4C)alkyl or (1-10C)alkyl {optionally substituted as defined for (R9c)};
R10 is selected from hydrogen, R9c (as hereinbefore defined), (1-4C)acyl and (1-4C)alkylsulfonyl;
HET-3 is selected from:
a) a 5-membered heterocyclic ring containing at least one nitrogen and/or oxygen in which any carbon atom is a C═O, C═N, or
C═S group, wherein said ring is of the formula HET3-A to HET3-E below:
![]() b) a carbon-linked 5- or 6-membered heteroaromatic ring containing 1, 2, 3, or 4 heteroatoms independently selected from N,
O and S selected from HET3-F to HET3-Y below:
![]() ![]() c) a nitrogen-linked 5- or 6-membered heteroaromatic ring containing 1, 2, 3, or 4 heteroatoms independently selected from
N, O and S selected from HET3-Z to HET3-AH below:
![]() wherein in HET-3, R1a is a substituent on carbon;
R1a is independently selected from R1a1 to R1a5 below:
R1a1: AR1, AR2, AR2a, AR2b, AR3, AR3a, AR3b, AR4, AR4a, CY1, CY2;
R1a2: cyano, carboxy, (1-4C)alkoxycarbonyl, —C(═W)NRvRw [wherein W is O or S, Rv and Rw are independently H, or (1-4C)alkyl
and wherein Rv and Rw taken together with the amide or thioamide nitrogen to which they are attached can form a 5-7 membered
ring optionally with an additional heteroatom selected from N, O, S(O)n in place of 1 carbon atom of the so formed ring; wherein
when said ring is a piperazine ring, the ring may be optionally substituted on the additional nitrogen by a group selected
from (1-4C)alkyl, (3-6C)cycloalkyl, (1-4C)alkanoyl, —COO(1-4C)alkyl, —S(O)n(1-4C)alkyl (wherein n=1 or 2), —COOAR1, —CS(1-4C)alkyl)
and —C(═S)O(1-4C)alkyl; wherein any (1-4C)alkyl, (1-4C)acyl and (1-4C)cycloalkyl substituent may itself be substituted by
cyano, hydroxy or halo, provided that, such a substituent is not on a carbon adjacent to a nitrogen atom of the piperazine
ring], ethenyl, 2-(1-4C)alkylethenyl, 2-cyanoethenyl, 2-cyano-2-((1-4C)alkyl)ethenyl, 2-nitroethenyl, 2-nitro-2-((1-4C)alkyl)ethenyl,
2-((1-4C)alkylaminocarbonyl)ethenyl, 2-((1-4C)alkoxycarbonyl)ethenyl, 2-(AR1)ethenyl, 2-(AR2)ethenyl, 2-(AR2a)ethenyl;
R1a3: (1-10C)alkyl
{optionally substituted by one or more groups (including geminal disubstitution) each independently selected from hydroxy,
(1-10C)alkoxy, (1-4C)alkoxy-(1-4C)alkoxy, (1-4C)alkoxy-(1-4C)alkoxy-(1-4C)alkoxy, (1-4C)alkylcarbonyl, phosphoryl [—O—P(O)(OH)2, and mono- and di-(1-4C)alkoxy derivatives thereof], phosphiryl [—O—P(OH)2 and mono- and di-(1-4C)alkoxy derivatives thereof], and amino; and/or optionally substituted by one group selected from carboxy,
phosphonate [phosphono, —P(O)(OH)2, and mono- and di-(1-4C)alkoxy derivatives thereof], phosphinate [—P(OH)2 and mono- and di-(1-4C)alkoxy derivatives thereof], cyano, halo, trifluoromethyl, (1-4C)alkoxycarbonyl, (1-4C)alkoxy-(1-4C)alkoxycarbonyl,
(1-4C)alkoxy-(1-4C)alkoxy-(1-4C)alkoxycarbonyl, (1-4C)alkylamino, di((1-4C)alkyl)amino, (1-6C)alkanoylamino-, (1-4C)alkoxycarbonylamino-,
N-(1-4C)alkyl-N-(1-6C)alkanoylamino-, —C(═W)NRvRw [wherein W is O or S, Rv and Rw are independently H, or (1-4C)alkyl and
wherein Rv and Rw taken together with the amide or thioamide nitrogen to which they are attached can form a 5-7 membered ring
optionally with an additional heteroatom selected from N, O, S(O)n in place of 1 carbon atom of the so formed ring; wherein
when said ring is a piperazine ring, the ring may be optionally substituted on the additional nitrogen by a group selected
from (1-4C)alkyl, (3-6C)cycloalkyl, (1-4C)alkanoyl, —COO(1-4C)alkyl, —S(O)n(1-4C)alkyl (wherein n=1 or 2), —COOAR1, —CS(1-4C)alkyl
and —C(═S)O(1-4C)alkyl], (═NORv) wherein Rv is as hereinbefore defined, (1-4C)alkylS(O)pNH—, (1-4C)alkylS(O)p-((1-4C)alkyl)N—, fluoro(1-4C)alkylS(O)pNH—, fluoro(1-4C)alkylS(O)p((1-4C)alkyl)N—, (1-4C)alkylS(O)q—, CY1, CY2, AR1, AR2, AR3, AR1-O—, AR2-O—, AR3-O—, AR1-S(O)q—, AR2-S(O)q—, AR3-S(O)q—, AR1-NH—, AR2-NH—, AR3-NH— (p is 1 or 2 and q is 0, 1 or 2), and also AR2a, AR2b, AR3a and AR3b versions of AR2 and AR3
containing groups}; wherein any (1-4C)alkyl,
(1-4C)alkanoyl and (3-6C)cycloalkyl present in any substituent on R1a3 may itself be substituted by one or two groups independently selected from cyano, hydroxy, halo, amino, (1-4C)alkylamino
and di(1-4C)alkylamino, provided that such a substituent is not on a carbon adjacent to a heteroatom atom if present;
R1a4: R14C(O)O(1-6C)alkyl- wherein R14 is AR1, AR2, AR2a, AR2b, (1-4C)alkylamino, benzyloxy-(1-4C)alkyl or (1-10C)alkyl {optionally substituted as defined for (R1a3)};
R1a5: F, Cl, hydroxy, mercapto, (1-4C)alkylS(O)p- (p=0, 1 or 2), —NR7R8 (wherein R7 and R8 are as hereinbefore defined) or —OR10 (where R10 is as hereinbefore defined);
m is 0, 1 or 2;
R21 is selected from hydrogen, methyl [optionally substituted with cyano, trifluoromethyl, —C═WNRvRw (where W, Rv and Rw are as
hereinbefore defined for R1a3), (1-4C)alkoxycarbonyl, (1-4C)alkoxy-(1-4C)alkoxycarbonyl, (1-4C)alkoxy-(1-4C)alkoxy-(1-4C)alkoxycarbonyl, CY1, CY2, AR1,
AR2, AR2a, AR2b (not linked through nitrogen) or AR3], (2-10C)alkyl [optionally substituted other than on a carbon attached
to the HET-3 ring nitrogen with one or two groups independently selected from the optional subsituents defined for R1a3] and R14C(O)O(2-6C)alkyl- wherein R14 is as defined hereinbefore for R1a4 and wherein R14C(O)O group is attached to a carbon other than the carbon attached to the HET-3 ring nitrogen;
R22 is cyano, —COR12, —COOR12, —CONHR12, —CON(R12)(R13), —SO2R12 (provided that R12 is not hydrogen), —SO2NHR12, —SO2N(R12)(R13) or NO2, wherein R12 and R13 are as defined hereinbelow;
R12 and R13 are independently selected from hydrogen, phenyl (optionally substituted with one or more substituents selected from halogen,
(1-4C)alkyl and (1-4C)alkyl substituted with one, two, three or more halogen atoms) and (1-4C)alkyl (optionally substituted
with one, two, three or more halogen atoms), or for any N(R12)(R13) group, R12 and R13 may be taken together with the nitrogen to which they are attached to form a 5-7 membered ring optionally with an additional
heteroatom selected from N, O, S(O)n in place of 1 carbon atom of the so formed ring; wherein the ring may be optionally substituted
by one or two groups independently selected from (1-4C)alkyl (optionally substituted on a carbon not adjacent to the nitrogen
by cyano, hydroxy or halo), (1-4C)cycloalkyl, (1-4C)alkanoyl, —COO(1-4C)alkano, —S(O)n(1-4C)alkyl (wherein n=1 or 2), AR1,
AR2, —C═OAR1, —C═OAR2, —COOAR1, —CS(1-4C)alkyl, —C(═S)O(1-4C)alkyl, —C(═W)NRvRw [wherein W is O or S, Rv and Rw are independently
H, or (1-4C)alkyl], —S(O)pAR1 and —S(O)pAR2; wherein any (1-4C)alkyl chain may be optionally substituted by (1-4C)alkyl, cyano,
hydroxy or halo; p=0, 1 or 2;
AR1 is an optionally substituted phenyl or optionally substituted naphthyl;
AR2 is an optionally substituted 5- or 6-membered, fully unsaturated (i.e with the maximum degree of unsaturation) monocyclic
heteroaryl ring containing up to four heteroatoms independently selected from O, N and S (but not containing any O—O, O—S
or S—S bonds), and linked via a ring carbon atom, or a ring nitrogen atom if the ring is not thereby quaternised;
AR2a is a partially hydrogenated version of AR2 (i.e. AR2 systems retaining some but not the full, degree of unsaturation),
linked via a ring carbon atom or linked via nitrogen atom if ring nitrogen atom if the ring is not thereby quaternised;
AR2b is a fully hydrogenated version of AR2 (i.e. AR2 systems having no unsaturation), linked via a ring carbon atom or linked
via a ring nitrogen atom;
AR3 is an optionally substituted 8-, 9- or 10-membered, fully unsaturated (i.e with the maximum degree of unsaturation) bicyclic
heteroaryl ring containing up to four heteroatoms independently selected from O, N and S (but not containing any O—O, O—S
or S—S bonds), and linked via a ring carbon atom in either of the rings comprising the bicyclic system;
AR3a is a partially hydrogenated version of AR3 (i.e. AR3 systems retaining some, but not the full degree of unsaturation),
linked via a ring carbon atom, or linked via a ring nitrogen atom if the ring is not thereby quaternised, in either of the
rings comprising the bicyclic system;
AR3b is a fully hydrogenated version of AR3 (i.e. AR3 systems having no unsaturation), linked via a ring carbon atom, or linked
via a ring nitrogen atom, in either of the rings comprising the bicyclic system;
AR4 is an optionally substituted 13- or 14-membered, fully unsaturated (i.e. with the maximum degree of unsaturation) tricyclic
heteroaryl ring containing up to four heteroatoms independently selected from O, N and S (but not containing any O—O, O—S
or S—S bonds), and linked via a ring carbon atom in any of the rings comprising the tricyclic system;
AR4a is a partially hydrogenated version of AR4 (i.e. AR4 systems retaining some, but not the full degree of unsaturation),
linked via a ring carbon atom, or linked via a ring nitrogen atom if the ring is not thereby quaternised, in any of the rings
comprising the tricyclic system;
CY1 is an optionally substituted cyclopentenyl or cyclohexenyl ring;
CY2 is an optionally substituted cyclopentenyl or cyclohexenyl ring;
wherein; optional substituents on AR1, AR2, AR2a, AR2b, AR3, AR3a, AR3b, AR4, AR4a, CY1 and CY2 are (on an available carbon
atom) up to three substituents independently selected from (1-4C)alkyl {optionally substituted by substituents selected independently
from hydroxy, trifluoromethyl, (1-4C)alkylS(O)q— (q is 0, 1 or 2), (1-4C)alkoxy,
(1-4C)alkoxycarbonyl, cyano, nitro, (1-4C)alkanoylamino, —CONRvRw or —NRvRw}, trifluoromethyl, hydroxy, halo, nitro, cyano,
thiol, (1-4C)alkoxy, (1-4C)alkanoyloxy, dimethylaminomethyleneaminocarbonyl, di(N-(1-4C)alkyl)aminomethylimino, carboxy, (1-4C)alkoxycarbonyl,
(1-4C)alkanoyl, (1-4C)alkylSO2amino, (2-4C)alkenyl {optionally substituted by carboxy or (1-4C)alkoxycarbonyl}, (2-4C)alkynyl, (1-4C)alkanoylamino, oxo
(═O), thioxo (═S), (1-4C)alkanoylamino {the (1-4C)alkanoyl group being optionally substituted by hydroxy}, (1-4C)alkyl S(O)q— (q is 0, 1 or 2) {the (1-4C)alkyl group being optionally substituted by one or more groups independently selected from cyano,
hydroxy and (1-4C)alkoxy}, —CONRvRw or —NRvRw [wherein Rv is hydrogen or (1-4C)alkyl; Rw is hydrogen or (1-4C)alkyl];
and further optional substituents on AR1, AR2, AR2a, AR2b, AR3, AR3a, AR3b, AR4, AR4a, CY1 and CY2 (on an available carbon
atom), and also on alkyl groups (unless indicated otherwise) are up to three substituents independently selected from trifluoromethoxy,
benzoylamino, benzoyl, phenyl {optionally substituted by up to three substituents independently selected from halo, (1-4C)alkoxy
or cyano}, furan, pyrrole, pyrazole, imidazole, triazole, pyrimidine, pyridazine, pyridine, isoxazole, oxazole, isothiazole,
thiazole, thiophene, hydroxyimino(1-4C)alkyl, (1-4C)alkoxyimino(1-4C)alkyl, halo-(1-4C)alkyl, (1-4C)alkanesulfonamido, —SO2NRvRw [wherein Rv is hydrogen or (1-4C)alkyl; Rw is hydrogen or (1-4C)alkyl]; and
optional substituents on AR2, AR2a, AR2b, AR3, AR3a, AR3b, AR4 and AR4a are (on an available nitrogen atom, where such substitution
does not result in quaternization) (1-4C)alkyl, (1-4C)alkanoyl {wherein the (1-4C)alkyl and (1-4C)alkanoyl groups are optionally
substituted by (preferably one) substituents independently selected from cyano, hydroxy, nitro, trifluoromethyl, (1-4C)alkyl
S(O)q— (q is 0, 1 or 2), (1-4C)alkoxy, (1-4C)alkoxycarbonyl, (1-4C)alkanoylamino, —CONRvRw or —NRvRw [wherein Rv is hydrogen or
(1-4C)alkyl; Rw is hydrogen or (1-4C)alkyl]}, (2-4C)alkenyl, (2-4C)alkynyl, (1-4C)alkoxycarbonyl or oxo (to form an N-oxide).
|